 | • レポートコード：D005-01035 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。結核治療の種類別市場規模（イソニアジド、リファンピン、ピラジナミド、ヒドラジン誘導体、その他抗結核薬、エタンブトール）、用途別市場規模（外来手術センター、病院薬局、個人薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Aventis Pharmaceuticals、Sigma Pharmaceutical Pty、Sanofi -Aventis、Bayer Health Care、Versapharma Incorporated、Hoffmann-La Roche、Novartis AG ・地域別グローバル市場分析 2015年-2020年 ・結核治療の北米市場（アメリカ、カナダ、メキシコ） ・結核治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核治療の南米市場（ブラジル、アルゼンチン） ・結核治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：イソニアジド、リファンピン、ピラジナミド、ヒドラジン誘導体、その他抗結核薬、エタンブトール ・用途別分析：外来手術センター、病院薬局、個人薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Tuberculosis Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 965.3 million by 2025, from USD 863.6 million in 2019.
The Tuberculosis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tuberculosis Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Therapeutics market has been segmented into:
Isoniazid
Rifampin
Pyrazinamide
Hydrazine Derivatives
Miscellaneous Anti-Tubercular Drugs
Ethambutol
By Application, Tuberculosis Therapeutics has been segmented into:
Ambulatory Surgical Centers
Hospital Pharmacies
Individual Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Therapeutics Market Share Analysis
Tuberculosis Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Therapeutics are:
Aventis Pharmaceuticals
Sigma Pharmaceutical Pty
Sanofi -Aventis
Bayer Health Care
Versapharma Incorporated
Hoffmann-La Roche
Novartis AG
Table of Contents
1 Tuberculosis Therapeutics Market Overview
1.1 Product Overview and Scope of Tuberculosis Therapeutics
1.2 Classification of Tuberculosis Therapeutics by Type
1.2.1 Global Tuberculosis Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Tuberculosis Therapeutics Revenue Market Share by Type in 2019
1.2.3 Isoniazid
1.2.4 Rifampin
1.2.5 Pyrazinamide
1.2.6 Hydrazine Derivatives
1.2.7 Miscellaneous Anti-Tubercular Drugs
1.2.8 Ethambutol
1.3 Global Tuberculosis Therapeutics Market by Application
1.3.1 Overview: Global Tuberculosis Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Ambulatory Surgical Centers
1.3.3 Hospital Pharmacies
1.3.4 Individual Pharmacies
1.4 Global Tuberculosis Therapeutics Market by Regions
1.4.1 Global Tuberculosis Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Tuberculosis Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Tuberculosis Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Tuberculosis Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tuberculosis Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Tuberculosis Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tuberculosis Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Aventis Pharmaceuticals
2.1.1 Aventis Pharmaceuticals Details
2.1.2 Aventis Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Aventis Pharmaceuticals SWOT Analysis
2.1.4 Aventis Pharmaceuticals Product and Services
2.1.5 Aventis Pharmaceuticals Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sigma Pharmaceutical Pty
2.2.1 Sigma Pharmaceutical Pty Details
2.2.2 Sigma Pharmaceutical Pty Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sigma Pharmaceutical Pty SWOT Analysis
2.2.4 Sigma Pharmaceutical Pty Product and Services
2.2.5 Sigma Pharmaceutical Pty Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi -Aventis
2.3.1 Sanofi -Aventis Details
2.3.2 Sanofi -Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi -Aventis SWOT Analysis
2.3.4 Sanofi -Aventis Product and Services
2.3.5 Sanofi -Aventis Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Health Care
2.4.1 Bayer Health Care Details
2.4.2 Bayer Health Care Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Health Care SWOT Analysis
2.4.4 Bayer Health Care Product and Services
2.4.5 Bayer Health Care Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Versapharma Incorporated
2.5.1 Versapharma Incorporated Details
2.5.2 Versapharma Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Versapharma Incorporated SWOT Analysis
2.5.4 Versapharma Incorporated Product and Services
2.5.5 Versapharma Incorporated Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hoffmann-La Roche
2.6.1 Hoffmann-La Roche Details
2.6.2 Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hoffmann-La Roche SWOT Analysis
2.6.4 Hoffmann-La Roche Product and Services
2.6.5 Hoffmann-La Roche Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novartis AG SWOT Analysis
2.7.4 Novartis AG Product and Services
2.7.5 Novartis AG Tuberculosis Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Tuberculosis Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Tuberculosis Therapeutics Players Market Share
3.2.2 Top 10 Tuberculosis Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Tuberculosis Therapeutics Revenue and Market Share by Regions
4.2 North America Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Tuberculosis Therapeutics Revenue by Countries
5.1 North America Tuberculosis Therapeutics Revenue by Countries (2015-2020)
5.2 USA Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Tuberculosis Therapeutics Revenue by Countries
6.1 Europe Tuberculosis Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Tuberculosis Therapeutics Revenue by Countries
7.1 Asia-Pacific Tuberculosis Therapeutics Revenue by Countries (2015-2020)
7.2 China Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Tuberculosis Therapeutics Revenue by Countries
8.1 South America Tuberculosis Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Tuberculosis Therapeutics by Countries
9.1 Middle East & Africa Tuberculosis Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Tuberculosis Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Therapeutics Market Forecast by Type (2019-2024)
10.3 Isoniazid Revenue Growth Rate (2015-2025)
10.4 Rifampin Revenue Growth Rate (2015-2025)
10.5 Pyrazinamide Revenue Growth Rate (2015-2025)
10.6 Hydrazine Derivatives Revenue Growth Rate (2015-2025)
10.7 Miscellaneous Anti-Tubercular Drugs Revenue Growth Rate (2015-2025)
10.8 Ethambutol Revenue Growth Rate (2015-2025)
11 Global Tuberculosis Therapeutics Market Segment by Application
11.1 Global Tuberculosis Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Tuberculosis Therapeutics Market Forecast by Application (2019-2024)
11.3 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.4 Hospital Pharmacies Revenue Growth (2015-2020)
11.5 Individual Pharmacies Revenue Growth (2015-2020)
12 Global Tuberculosis Therapeutics Market Size Forecast (2021-2025)
12.1 Global Tuberculosis Therapeutics Market Size Forecast (2021-2025)
12.2 Global Tuberculosis Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Tuberculosis Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Tuberculosis Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Aventis Pharmaceuticals Corporate Information, Location and Competitors
Table 6. Aventis Pharmaceuticals Tuberculosis Therapeutics Major Business
Table 7. Aventis Pharmaceuticals Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Aventis Pharmaceuticals SWOT Analysis
Table 9. Aventis Pharmaceuticals Tuberculosis Therapeutics Product and Solutions
Table 10. Aventis Pharmaceuticals Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sigma Pharmaceutical Pty Corporate Information, Location and Competitors
Table 12. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Major Business
Table 13. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Sigma Pharmaceutical Pty SWOT Analysis
Table 15. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Product and Solutions
Table 16. Sigma Pharmaceutical Pty Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi -Aventis Corporate Information, Location and Competitors
Table 18. Sanofi -Aventis Tuberculosis Therapeutics Major Business
Table 19. Sanofi -Aventis Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi -Aventis SWOT Analysis
Table 21. Sanofi -Aventis Tuberculosis Therapeutics Product and Solutions
Table 22. Sanofi -Aventis Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Health Care Corporate Information, Location and Competitors
Table 24. Bayer Health Care Tuberculosis Therapeutics Major Business
Table 25. Bayer Health Care Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Bayer Health Care SWOT Analysis
Table 27. Bayer Health Care Tuberculosis Therapeutics Product and Solutions
Table 28. Bayer Health Care Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Versapharma Incorporated Corporate Information, Location and Competitors
Table 30. Versapharma Incorporated Tuberculosis Therapeutics Major Business
Table 31. Versapharma Incorporated Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Versapharma Incorporated SWOT Analysis
Table 33. Versapharma Incorporated Tuberculosis Therapeutics Product and Solutions
Table 34. Versapharma Incorporated Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 36. Hoffmann-La Roche Tuberculosis Therapeutics Major Business
Table 37. Hoffmann-La Roche Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Hoffmann-La Roche SWOT Analysis
Table 39. Hoffmann-La Roche Tuberculosis Therapeutics Product and Solutions
Table 40. Hoffmann-La Roche Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Novartis AG Corporate Information, Location and Competitors
Table 42. Novartis AG Tuberculosis Therapeutics Major Business
Table 43. Novartis AG Tuberculosis Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Novartis AG SWOT Analysis
Table 45. Novartis AG Tuberculosis Therapeutics Product and Solutions
Table 46. Novartis AG Tuberculosis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Tuberculosis Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 48. Global Tuberculosis Therapeutics Revenue Share by Players (2015-2020)
Table 49. Global Tuberculosis Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Tuberculosis Therapeutics Revenue Market Share by Regions (2015-2020)
Table 51. North America Tuberculosis Therapeutics Revenue by Countries (2015-2020)
Table 52. North America Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 53. Europe Tuberculosis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Tuberculosis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Tuberculosis Therapeutics Revenue by Countries (2015-2020)
Table 56. South America Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Tuberculosis Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Global Tuberculosis Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 60. Global Tuberculosis Therapeutics Revenue Share by Type (2015-2020)
Table 61. Global Tuberculosis Therapeutics Revenue Forecast by Type (2021-2025)
Table 62. Global Tuberculosis Therapeutics Revenue by Application (2015-2020)
Table 63. Global Tuberculosis Therapeutics Revenue Share by Application (2015-2020)
Table 64. Global Tuberculosis Therapeutics Revenue Forecast by Application (2021-2025)
Table 65. Global Tuberculosis Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Tuberculosis Therapeutics Picture
Figure 2. Global Tuberculosis Therapeutics Revenue Market Share by Type in 2019
Figure 3. Isoniazid Picture
Figure 4. Rifampin Picture
Figure 5. Pyrazinamide Picture
Figure 6. Hydrazine Derivatives Picture
Figure 7. Miscellaneous Anti-Tubercular Drugs Picture
Figure 8. Ethambutol Picture
Figure 9. Tuberculosis Therapeutics Revenue Market Share by Application in 2019
Figure 10. Ambulatory Surgical Centers Picture
Figure 11. Hospital Pharmacies Picture
Figure 12. Individual Pharmacies Picture
Figure 13. Global Tuberculosis Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Tuberculosis Therapeutics Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Tuberculosis Therapeutics Revenue Market Share in 2019
Figure 22. Global Top 10 Players Tuberculosis Therapeutics Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Tuberculosis Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 26. Global Tuberculosis Therapeutics Revenue Market Share by Regions in 2018
Figure 27. North America Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Europe Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. South America Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. North America Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 33. North America Tuberculosis Therapeutics Revenue Market Share by Countries in 2019
Figure 34. USA Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Canada Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. Europe Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Tuberculosis Therapeutics Revenue Market Share by Countries in 2019
Figure 39. Germany Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. UK Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. France Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Russia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Italy Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Tuberculosis Therapeutics Revenue Market Share by Countries in 2019
Figure 46. China Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Japan Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Korea Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. India Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. South America Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. South America Tuberculosis Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Brazil Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Tuberculosis Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Tuberculosis Therapeutics Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. UAE Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Tuberculosis Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. Global Tuberculosis Therapeutics Revenue Share by Type (2015-2020)
Figure 62. Global Tuberculosis Therapeutics Revenue Share by Type in 2019
Figure 63. Global Tuberculosis Therapeutics Market Share Forecast by Type (2021-2025)
Figure 64. Global Isoniazid Revenue Growth Rate (2015-2020)
Figure 65. Global Rifampin Revenue Growth Rate (2015-2020)
Figure 66. Global Pyrazinamide Revenue Growth Rate (2015-2020)
Figure 67. Global Hydrazine Derivatives Revenue Growth Rate (2015-2020)
Figure 68. Global Miscellaneous Anti-Tubercular Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Ethambutol Revenue Growth Rate (2015-2020)
Figure 70. Global Tuberculosis Therapeutics Revenue Share by Application (2015-2020)
Figure 71. Global Tuberculosis Therapeutics Revenue Share by Application in 2019
Figure 72. Global Tuberculosis Therapeutics Market Share Forecast by Application (2021-2025)
Figure 73. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 74. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 75. Global Individual Pharmacies Revenue Growth Rate (2015-2020)
Figure 76. Global Tuberculosis Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Tuberculosis Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Tuberculosis Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Europe Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. South America Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Tuberculosis Therapeutics Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
結核薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 965.3 million by 2025, from USD 863.6 million in 2019. The Tuberculosis Drugs …- 結核治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tuberculosis Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis Tre…
- 結核診断の世界市場 2020年：企業別、地域別、種類・用途別 Summary Market Overview The global Tuberculosis Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis…
- 結核ワクチン治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…
- 結核診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Diagnosis and Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tubercul…